Charles Morgan Kendrick Jr. - 01 Mar 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP & President, Commercial
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol: ELV
Transactions as of: 01 Mar 2023
Net transactions value: -$645,583
Form type: 4
Filing time: 03 Mar 2023, 15:19:14 UTC
Previous filing: 03 Nov 2022
Next filing: 13 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Tax liability	$137,426	-293	-2%	$469.03	14,157	01 Mar 2023	Direct	F1
transaction	ELV	Common Stock	Award	$0	+2,026	+14%	$0.000000	16,183	01 Mar 2023	Direct	F2
transaction	ELV	Common Stock	Award	$0	+2,542	+16%	$0.000000	18,725	01 Mar 2023	Direct	F3
transaction	ELV	Common Stock	Tax liability	$508,158	-1,084	-5.8%	$468.78	17,641	02 Mar 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award	$0	+7,786		$0.000000	7,786	01 Mar 2023	Common Stock	7,786	$469.03	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2	Represents restricted share units. Restrictions lapse as follows: 675 shares each on 3/1/2024 and 3/1/2025 and 676 shares on 3/1/2026.
F3	Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
F4	The option represents a right to purchase a total of 7,786 shares, and is exercisable in two installments of 2,595 shares each and one installment of 2,596 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.